SCHEMBL9936757

SCHEMBL9936757

CNCCc1nc2c(N3CCOCC3)nc(Cl)nc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
TACR2 P21452 2/20 0.34
HDAC1 Q13547 1/20 0.34
SLC29A1 Q99808 1/20 0.33
CYP3A4 P08684 1/20 0.32
PDE10A Q9Y233 1/20 0.31
SYK P43405 1/20 0.31
MAPT P10636 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
NUDT1 P36639 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30
PDE4C Q08493 1/20 0.30
PDE4D Q08499 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25391517 0.83 SMN1; SMN2 (0.38) SMN1; SMN2HDAC1SLC29A1CYP3A4MAPT
SCHEMBL9936656 0.82 SLC29A1 (0.41) SMN1; SMN2HDAC1SLC29A1MAPTL3MBTL1
SCHEMBL9938207 0.82 SMN1; SMN2 (0.34) SMN1; SMN2TACR2HDAC1SLC29A1
SCHEMBL9935756 0.81 ADORA1 (0.37) HDAC1CYP3A4KDM4E
SCHEMBL25390708 0.81 HPGD (0.42) SMN1; SMN2HDAC1SLC29A1MAPTL3MBTL1
SCHEMBL25229494 0.78 SMN1; SMN2 (0.42) SMN1; SMN2TACR2HDAC1SLC29A1CYP3A4
SCHEMBL3325399 0.77 SMN1; SMN2 (0.41) SMN1; SMN2HDAC1SLC29A1MAPTL3MBTL1
SCHEMBL25391923 0.77 SMN1; SMN2 (0.37) SMN1; SMN2HDAC1SLC29A1CYP3A4MAPT
SCHEMBL9937094 0.75 HDAC1 (0.41) SMN1; SMN2HDAC1L3MBTL1KDM4EPDE4B
SCHEMBL31339118 0.75 PIM1 (0.40) SMN1; SMN2HDAC1SLC29A1PDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651951-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2013-10-23 EP disclosed
WO-2012082997-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA-ROCHE AG (CH) 2012-06-21 WO disclosed